Work

Phase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

Year: 2019

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz253.033

Authors: A. Rajan, J.E. Gray, S. Devarakonda, J. Gurtler, R. Birhiray, E. Paschold, A. Dasgupta, C. Heery, C. Pico-Navarro, M. Piechatzek, E. Wagner, E. Menius, R.N. Donahue, J. Schlom, J.L. Gulley

Institutions: National Institutes of Health, National Cancer Institute, University of South Florida, Moffitt Cancer Center, Washington University in St. Louis, Novant Health Forsyth Medical Center, Bavarian Nordic (United States), Bavarian Nordic (Germany), Center for Cancer Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2977477156

FWCI: 0.091

Cites:

Cited by: 2

Related to: 10